Source: Reuters - Pfizer Inc (PFE.N) said on Monday it has started a large study testing its investigational oral antiviral drug for the prevention of COVID-19 infection among those who have been exposed to the virus. The drugmaker and its rivals, including U.S.-based Merck & Co Inc (MRK.N) and Swiss pharmaceutical Roche Holding AG (ROG.S), […]
The post WORLD - Pfizer begins study of oral drug for prevention of COVID-19 appeared first on Barbados Today.
